Anesthetic Effectiveness of Lidocaine Versus Articaine in Dentistry

NCT ID: NCT07231614

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE4

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-20

Study Completion Date

2026-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Context: Lidocaine and articaine are two of the most commonly used local anesthetics in dentistry. Lidocaine has often been the anesthetic of choice in clinical practice, but in clinical experience, articaine has proven to be more effective in controlling pain during dental procedures. (Camps-Font, O. et al. 2020).

There are still unanswered questions, such as which of the two local anesthetics is more effective in reducing pain? This could lead us to discuss which one to choose to reduce costs in the dental office.

Objective: The objective of this project is to determine and compare the effectiveness of lidocaine and articaine in clinical contexts such as tooth extraction with infiltrative techniques, seeking to provide answers that will optimize the choice of anesthetic based on the patient and the procedure, thus improving pain management and reducing costs in the dental office.

Design: Randomized double-blind experimental study, parallel groups. The control group received 2% lidocaine, and the experimental group received 4% articaine. The study will be conducted in accordance with the guidelines of the Consolidated Standards of Reporting Trials (CONSORT 2010). The probabilistic sampling technique is through simple randomization. The 100 patients who meet the inclusion criteria will be randomly assigned to the control and experimental groups in a 1:1 ratio.

Expected results: articaine shows a lower percentage of extractions with anesthetic reinforcement and, therefore, a lower average number of additional tubes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, double-blind, parallel-group experimental study. Control group: 2% lidocaine; experimental group: 4% articaine. The RCT will be conducted in accordance with the Consolidated Standards of Reporting Trials (CONSORT 2010) guidelines.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers
Blinding will be performed by the study investigators. The RCT is a double-blind trial, where neither the operator nor the patient knows the result of the anesthesia being administered.

The preparation of the intervention will be carried out by dividing the anesthetic cartridges, 50 for the control group (lidocaine) and 50 for the experimental group (articaine).

Since both articaine and lidocaine are from the same manufacturer, they have the same color silicone plunger, so we will simply cover the logo with an adhesive sticker and store them in a box. To distinguish which of the tubes corresponds to articaine or lidocaine once they have the sticker, they will be assigned the same numbers that will be used to randomize each patient (1 and 2 interleaved), with No. 1 being articaine and No. 2 being lidocaine. These will be in their respective boxes with their numbering.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lidocaine

Participant in this group will receive lidocaine as a local anesthetic during dental procedures.

Group Type ACTIVE_COMPARATOR

lidocaine + epinephrine 1:100,000

Intervention Type DRUG

Administration of lidocaine as a local anesthetic during dental extraction.

Articaine

Participant in this group will receive articaine as a local anesthetic during dental procedures.

Group Type EXPERIMENTAL

Articaine 4% with epinephrine 1:100,000

Intervention Type DRUG

Administration of articaine as a local anesthetic during dental extraction.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lidocaine + epinephrine 1:100,000

Administration of lidocaine as a local anesthetic during dental extraction.

Intervention Type DRUG

Articaine 4% with epinephrine 1:100,000

Administration of articaine as a local anesthetic during dental extraction.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with clinical indications for simple extraction of upper and lower teeth using infiltrative anesthetic techniques.
* Patients without systemic diseases (ASA I)
* Patients with controlled systemic disease (ASA II)
* Patients with no history of hypersensitivity to anesthetics or their components (epinephrine)
* Patients with stable periodontal condition, without active infection that could affect the diffusion of the anesthetic.
* Patients with the ability to understand the procedure and provide informed consent.

Exclusion Criteria

* Patients with uncontrolled systemic diseases ASA III and pregnant patients.
* Patients requiring trunk techniques (Gow gates, Spix, Carrea)
* Patients taking medication that affects the anesthetic response (tricyclic antidepressants, anticoagulants)
* Patients with a history of neurological or psychiatric disorders that may influence the perception of pain or anxiety.
* Patients with anatomical abnormalities in the orofacial region that interfere with the administration or action of anesthesia.
* Patients with a history of recent substance abuse.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Austral de Chile

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Juan E Kunstmann, Dr. Dental Surgeon Dentistry

Role: STUDY_DIRECTOR

Universidad Austral de Chile

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CESFAM Dr. Jorge Sabat

Valdivia, Los Ríos Region, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Natalia A Curín, Student

Role: CONTACT

+56947029930

Camila A Henriquez, Student

Role: CONTACT

+56954911248

References

Explore related publications, articles, or registry entries linked to this study.

Halabi D, Escobar J, Alvarado C, Martinez N, Munoz C. Chlorhexidine for prevention of alveolar osteitis: a randomised clinical trial. J Appl Oral Sci. 2018;26:e20170245. doi: 10.1590/1678-7757-2017-0245. Epub 2018 May 7.

Reference Type RESULT
PMID: 29742264 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Informed Consent Form

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://docs.google.com/document/d/1DyLS_JgvWUSH5O9500IlCAwhV9ZJgvs4GNm3iLq89cg/edit?usp=sharing

Document that describes in detail the objectives, methodology, and procedures of the clinical trial.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ArtiVsLido

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.